Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | PRTK | Common Stock | Award | $0 | +169K | +13.97% | $0.00 | 1.38M | Aug 8, 2023 | Direct | F1 |
transaction | PRTK | Common Stock | Sale | -$108K | -49K | -3.56% | $2.20 | 1.33M | Aug 9, 2023 | Direct | F2, F3 |
Id | Content |
---|---|
F1 | Represents performance-based restricted stock units ("PRSUs") granted on March 30, 2021 to the Reporting Person under the Paratek Pharmaceuticals, Inc. 2015 Equity Incentive Plan that vested on August 8, 2023. |
F2 | Sale of shares to cover personal income tax obligations upon vesting of PRSUs. |
F3 | The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions ranging from $2.19 to $2.21. The Reporting Person undertakes to provide to Paratek Pharmaceuticals, Inc., any security holder of Paratek Pharmaceuticals, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote 3 to this Form 4. |